NEWMARK

Private Equity Firms Pouring Millions Into Physician Offices

Article written by Morgan Haefner, Becker's Hospital CFO Report, August 23, 2018

Several private equity firms are investing in primary care clinic operators, driven in part by greater employer pressure to lower medical costs, according to Bloomberg.

Here are three things to know:

1. Private investor New Enterprise Associates led a $165 million funding round for Paladina Health, a Denver-based primary care company. Paladina runs 53 primary care clinics in 10 states for employers. Earlier this year, NEA acquired Paladina for about $100 million from DaVita. Paladina plans to use the funds to expand its clinics, acquire other firms and look into caring for Medicare populations... Read the full article here.

temp-post-image

All information contained in this publication is derived from sources that are deemed to be reliable. However, Newmark has not verified any such information, and the same constitutes the statements and representations only of the source thereof, and not of Newmark. Any recipient of this publication should independently verify such information and all other information that may be material to any decision that recipient may make in response to this publication, and should consult with professionals of the recipient's choice with regard to all aspects of that decision, including its legal, financial, and tax aspects and implications. Any recipient of this publication may not, without the prior written approval of Newmark, distribute, disseminate, publish, transmit, copy, broadcast, upload, download, or in any other way reproduce this publication or any of the information it contains. This document is intended for informational purposes only and none of the content is intended to advise or otherwise recommend a specific strategy. It is not to be relied upon in any way to predict market movement, investment in securities, transactions, investment strategies or any other matter.

Download Our
Brochure

Sign Up for Our Newsletter

VIEW 2022 HEALTHCARE OUTLOOK